Generics 2

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Vincristine manufacturers

2 products found

Filters

Filters

Filters , active

Country of origin : China

Clear all

2 products found

vincristine

Injection 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #36862

Manufacturer usually replies in 80 days

Want to see all 2 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Vincristine is a chemotherapic medication used to treat a variety of cancers, including acute lymphocytic leukemia, acute myeloid leukemia, Hodgkin's disease, neuroblastoma, and small cell lung cancer. Suppliers market it in the form of an intravenous solution. The drug was developed and first introduced to the market in 1963 and initially marketed by supplier Eli Lilly. Since then, other manufacturing companies, such as Teva, Pfizer, and Gedeon Richter have joined the market with their vincristine formulations. As of now, the medication is available in both generic and trade name forms and the World Health Organization has included it in its list of Essential Medicines needed for a basic health system. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. 1ml unit of 1mg/ml vincristine solution costs approximately 8.00 EUR.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.